GENNEX LAB. Fact Sheet, GENNEX LAB. Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENNEX LAB. Fact Sheet    (PPHM)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of GENNEX LAB.. For more details, see the GENNEX LAB. quarterly results and GENNEX LAB. share price and chart. For a sector overview, read our pharmaceuticals sector report.

GENNEX LAB. Price History

Price Rs 10.1
Mkt Cap Rs m 1,281
Vol '000 542.1
P/E X 24.5
P/CF X 26.1
EPS (TTM) Rs 0.4
1 Day % 5.0
No. of shares m 126.50
1 Week % -4.6
1 Month % 25.1
1 Year % 108.4
52 week H/L Rs 12.9/3.6
As on Jan 25, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GENNEX LAB. Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
GENNEX LAB. EQUITY SHARE DATA
High Rs98646 
Low Rs43212 
Sales per share (Unadj.) Rs3.23.24.14.14.4 
Earnings per share (Unadj.) Rs0.20.10.20.10.3 
Diluted earnings per shareRs0.20.10.20.10.3 
Cash flow per share (Unadj.) Rs0.30.10.30.20.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Avg Dividend yield %00000 
Book value per share (Unadj.) Rs2.42.52.72.83.1 
Adj. book value per shareRs2.42.52.72.83.1 
Shares outstanding (eoy) m126.50126.50126.50126.50126.50 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.11.81.00.70.9 
Avg P/E ratio x31.184.722.619.512.3 
P/CF ratio (eoy) x23.840.315.712.610.1 
Price / Book Value ratio x2.72.21.51.01.3 
Dividend payout %00000 
Avg Mkt Cap Rs m842708503361498 
No. of employees `000NANANANANA 
Total wages/salary Rs m5055616872 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
GENNEX LAB. INCOME DATA
Net Sales Rs m403403516513556 
Other income Rs m198105 
Total revenues Rs m404412524522562 
Gross profit Rs m4522403462 
Depreciation Rs m8910109 
Interest Rs m77887 
Profit before tax Rs m3115302551 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m468710 
Profit after tax Rs m278221940 
Gross profit margin %11.25.57.86.511.1 
Effective tax rate %12.842.526.627.220.2 
Net profit margin %6.72.14.33.67.3 
GENNEX LAB. BALANCE SHEET DATA
Current assets Rs m262277290350377 
Current liabilities Rs m171177173209190 
Net working cap to sales %22.624.822.727.533.5 
Current ratio x1.51.61.71.72.0 
Inventory Days Days6565505047 
Debtors Days Days93957344,699,36058,680,596 
Net fixed assets Rs m230228227220212 
Share capital Rs m127127127127127 
"Free" reserves Rs m183191212230271 
Net worth Rs m309318338357397 
Long term debt Rs m24000 
Total assets Rs m492505517569589 
Interest coverage x5.43.04.84.47.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.80.81.00.90.9 
Return on assets %6.93.15.84.68.1 
Return on equity %8.72.66.65.210.2 
Return on capital %12.26.811.39.314.6 
Exports to sales %32.629.245.542.941.2 
Imports to sales %3.75.114.214.54.4 
Exports (fob) Rs m132118235220229 
Imports (cif) Rs m1520737424 
Fx inflow Rs m132118235220229 
Fx outflow Rs m1728817929 
Net fx Rs m11590153141201 
GENNEX LAB. CASH FLOW
From Operations Rs m -1 32 19 -17 -14 
From Investments Rs m -10 -7 -10 -2 0 
From Financial Activity Rs m 9 -21 12 -3 16 
Net Cashflow Rs m -2 4 21 -22 2 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 22.1%
Institution 0.0%
Non-Institution 78.0%
Total 100.0%
Free Float 78.0%
Pledged promoter holdings 8.1%
Shareholding as on Dec 2021
 

Company Information

Regd Off Sy . No . 133, Bollaram, Jinnaram Mandal Medak Dist, Bollaram - 502325
E-mail investorrelations@gennexlab.com Web www.gennexlab.com
Tel 08458-279516 /279406 Fax 08458-279516
Sector PHARMACEUTICALS Group Private sector
Tr Agent R&D Infotech Pvt Ltd, 15 C Ground Floor, Naresh Mitra Sarani (Beltala Road) Road
YEAR OF INC: 1990 BSE CODE: 531739 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare GENNEX LAB. With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Sensex, Nifty Recover from Day's Low to End Higher; Maruti Suzuki Hits New High Post Q3 Results(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks (Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GENNEX LAB.

  • Track your investment in GENNEX LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENNEX LAB.

GENNEX LAB. - MYLAN COMPARISON

COMPARE GENNEX LAB. WITH

MARKET STATS